Home>
US Stocks>
Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc share price today

(CPIX)

Cumberland Pharmaceuticals Inc share price is $1.24 & ₹104.96 as on 7 Dec 2024, 2.30 'hrs' IST

$1.24

▲

0.06

(4.66%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Cumberland Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Cumberland Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Cumberland Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Cumberland Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Cumberland Pharmaceuticals Inc's financials.

Cumberland Pharmaceuticals Inc share price movements

$1.18
$1.28
$1.24
4.84%
Downside
Day's Volatility :7.81%
Upside
3.13%
$1.04
$2.36
$1.24
16.13%
Downside
52 Weeks Volatility :55.91%
Upside
47.43%

Cumberland Pharmaceuticals Inc Returns

Period	Cumberland Pharmaceuticals Inc	Index (Russel 2000)
3 Months	-8.53%	0.0%
6 Months	-16.9%	0.0%
1 Year	-33.71%	0.0%
3 Years	-79.58%	-19.7%

Cumberland Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close	$1.18
Open	$1.21
Today's High	$1.28
Today's Low	$1.18
Market Capitalization	$16.6M
Today's Volume	$39.2K
52 Week High	$2.3587
52 Week Low	$1.04
Revenue TTM	$36.8M
EBITDA	$-2.8M
Earnings Per Share (EPS)	$-0.76
Profit Margin	-29.55%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-36.07%

How to invest in Cumberland Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Cumberland Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cumberland Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Cumberland Pharmaceuticals Inc or CPIX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cumberland Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cumberland Pharmaceuticals Inc shares which would translate to 0.683 fractional shares of Cumberland Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Cumberland Pharmaceuticals Inc

250%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Cumberland Pharmaceuticals Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 250% more investors are searching Cumberland Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Cumberland Pharmaceuticals Inc

Renaissance Technologies Corp
3.76%
Vanguard Group Inc
2.67%
Bridgeway Capital Management, LLC
2.04%
Dimensional Fund Advisors, Inc.
2.02%
BlackRock Inc
0.79%
Bank of New York Mellon Corp
0.54%

Analyst Recommendation on Cumberland Pharmaceuticals Inc

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Cumberland Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cumberland Pharmaceuticals Inc

What analysts predicted

Upside of 585.48%

Current:

$1.24

Target:

$8.50

Insights on Cumberland Pharmaceuticals Inc

Decreasing Revenue
Revenue is down for the last 2 quarters, 9.84M → 9.08M (in $), with an average decrease of 7.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.08M → -1.54M (in $), with an average decrease of 42.2% per quarter
Vs CTLT
In the last 1 year, Catalent, Inc. has given 63.7% return, outperforming this stock by 92.6%
Vs NBIX
In the last 3 years, Cumberland Pharmaceuticals Inc has experienced a drawdown of -83.0%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 34.4%

Cumberland Pharmaceuticals Inc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$40.7M	↓ 0.99%
Net Income	$-7.0M	↓ 12.73%
Net Profit Margin	-17.09%	↑ 2.3%

	FY19	Y/Y Change
Revenue	$34.4M	↓ 15.59%
Net Income	$-9.2M	↑ 32.29%
Net Profit Margin	-26.79%	↓ 9.7%

	FY20	Y/Y Change
Revenue	$37.4M	↑ 8.88%
Net Income	$-6.6M	↓ 28.07%
Net Profit Margin	-17.7%	↑ 9.09%

	FY21	Y/Y Change
Revenue	$36.0M	↓ 3.89%
Net Income	$-5.6M	↓ 15.53%
Net Profit Margin	-15.55%	↑ 2.15%

	FY22	Y/Y Change
Revenue	$42.0M	↑ 16.75%
Net Income	$-5.7M	↑ 0.95%
Net Profit Margin	-13.45%	↑ 2.1%

	FY23	Y/Y Change
Revenue	$39.6M	↓ 5.85%
Net Income	$-6.3M	↑ 11.14%
Net Profit Margin	-15.88%	↓ 2.43%

	Q2 FY23	Q/Q Change
Revenue	$10.9M	↑ 18.04%
Net Income	$872.2K	↑ 353.84%
Net Profit Margin	8.01%	↑ 5.93%

	Q3 FY23	Q/Q Change
Revenue	$10.1M	↓ 7.37%
Net Income	$-1.0M	↓ 220.3%
Net Profit Margin	-10.4%	↓ 18.41%

	Q4 FY23	Q/Q Change
Revenue	$9.4M	↓ 7.27%
Net Income	$-6.3M	↑ 499.55%
Net Profit Margin	-67.26%	↓ 56.86%

	Q1 FY24	Q/Q Change
Revenue	$8.5M	↓ 9.15%
Net Income	$-1.9M	↓ 69.06%
Net Profit Margin	-22.9%	↑ 44.36%

	Q2 FY24	Q/Q Change
Revenue	$9.8M	↑ 15.9%
Net Income	$-1.1M	↓ 44.22%
Net Profit Margin	-11.02%	↑ 11.88%

	Q3 FY24	Q/Q Change
Revenue	$9.1M	↓ 7.75%
Net Income	$-1.5M	↑ 42.23%
Net Profit Margin	-16.99%	↓ 5.97%

	FY18	Y/Y Change
Total Assets	$112.7M	↑ 20.87%
Total Liabilities	$57.1M	↑ 94.89%

	FY19	Y/Y Change
Total Assets	$104.5M	↓ 7.23%
Total Liabilities	$53.5M	↓ 6.41%

	FY20	Y/Y Change
Total Assets	$96.5M	↓ 7.73%
Total Liabilities	$49.6M	↓ 7.25%

	FY21	Y/Y Change
Total Assets	$84.5M	↓ 12.44%
Total Liabilities	$41.9M	↓ 15.59%

	FY22	Y/Y Change
Total Assets	$92.9M	↑ 10.02%
Total Liabilities	$57.0M	↑ 36.06%

	FY23	Y/Y Change
Total Assets	$81.8M	↓ 12.0%
Total Liabilities	$52.5M	↓ 7.79%

	Q2 FY23	Q/Q Change
Total Assets	$89.4M	↓ 0.1%
Total Liabilities	$52.5M	↓ 1.65%

	Q3 FY23	Q/Q Change
Total Assets	$87.8M	↓ 1.82%
Total Liabilities	$52.1M	↓ 0.84%

	Q4 FY23	Q/Q Change
Total Assets	$81.8M	↓ 6.81%
Total Liabilities	$52.5M	↑ 0.81%

	Q1 FY24	Q/Q Change
Total Assets	$81.5M	↓ 0.33%
Total Liabilities	$54.3M	↑ 3.43%

	Q2 FY24	Q/Q Change
Total Assets	$78.5M	↓ 3.67%
Total Liabilities	$52.5M	↓ 3.37%

	Q3 FY24	Q/Q Change
Total Assets	$76.7M	↓ 2.26%
Total Liabilities	$52.3M	↓ 0.4%

	FY18	Y/Y Change
Operating Cash Flow	$3.1M	↓ 658.12%
Investing Cash Flow	$-27.7M	↓ 391.45%
Financing Cash Flow	$7.1M	↑ 266.5%

	FY19	Y/Y Change
Operating Cash Flow	$3.1M	↓ 1.81%
Investing Cash Flow	$2.3M	↓ 108.29%
Financing Cash Flow	$-5.1M	↓ 171.17%

	FY20	Y/Y Change
Operating Cash Flow	$5.4M	↑ 77.17%
Investing Cash Flow	$-1.8M	↓ 176.5%
Financing Cash Flow	$-7.1M	↑ 40.07%

	FY21	Y/Y Change
Operating Cash Flow	$6.3M	↑ 17.13%
Investing Cash Flow	$-501.9K	↓ 71.45%
Financing Cash Flow	$-3.6M	↓ 50.06%

	FY22	Y/Y Change
Operating Cash Flow	$8.5M	↑ 33.28%
Investing Cash Flow	$-13.7M	↑ 2624.58%
Financing Cash Flow	$-2.1M	↓ 41.98%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$5.2M	↓ 469.15%
Investing Cash Flow	$-96.8K	↑ 0.0%
Financing Cash Flow	$-3.3M	↑ 84.11%

Cumberland Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Cumberland Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cumberland Pharmaceuticals Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cumberland Pharmaceuticals Inc	-1.26%	-16.9%	-33.71%	-79.58%	-77.35%
Neurocrine Biosciences Inc.	0.89%	-6.15%	7.79%	50.04%	11.14%
Haleon Plc Spon Ads	1.99%	16.11%	18.8%	31.31%	31.31%
Zoetis Inc.	2.58%	-2.27%	-5.33%	-23.89%	44.16%
Viatris Inc.	11.02%	22.65%	31.13%	3.7%	-21.11%
Catalent, Inc.	3.62%	10.55%	67.08%	-51.26%	19.32%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cumberland Pharmaceuticals Inc	NA	NA	0.0	0.0	-0.36	-0.06	NA	1.77
Neurocrine Biosciences Inc.	33.98	33.98	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.36	29.36	1.74	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	32.98	32.98	2.44	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	514.17	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cumberland Pharmaceuticals Inc	Sell	$16.6M	-77.35%	NA	-29.55%
Neurocrine Biosciences Inc.	Buy	$12.9B	11.14%	33.98	17.21%
Haleon Plc Spon Ads	Buy	$43.8B	31.31%	29.36	10.75%
Zoetis Inc.	Buy	$79.1B	44.16%	32.98	26.55%
Viatris Inc.	Hold	$15.1B	-21.11%	224.4	-5.87%
Catalent, Inc.	Hold	$11.2B	19.32%	211.02	-9.34%

About Cumberland Pharmaceuticals Inc

cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.

Organization	Cumberland Pharmaceuticals Inc
Employees	91
CEO	Mr. A. J. Kazimi MBA
Industry	Health Technology

Management People of Cumberland Pharmaceuticals Inc

Name	Title
Mr. A. J. Kazimi MBA	Founder, Chairman, President & CEO
Mr. John Michael Hamm C.M.A.	VP & CFO
Mr. James Lowrance Herman	Executive VP of National Accounts & Chief Compliance Officer
Mr. Chris T. Bitterman	Vice President of Sales & Marketing
Mr. Todd M. Anthony	Vice President of Organizational Development
Ms. Jean W. Marstiller	Senior VP of Administrative Services & Corporate Secretary
Mr. Adam S. Mostafa	Managing Director
Ms. Erin Smith Gull	Senior Corporate Relations Associate

Important FAQs about investing in Cumberland Pharmaceuticals Inc from India :

What is Cumberland Pharmaceuticals Inc share price today?

Cumberland Pharmaceuticals Inc (CPIX) share price today is $1.24.

Can Indians buy Cumberland Pharmaceuticals Inc shares?

Yes, Indians can invest in the Cumberland Pharmaceuticals Inc (CPIX) from India.

With INDmoney, you can buy Cumberland Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cumberland Pharmaceuticals Inc at zero transaction cost.

How can I buy Cumberland Pharmaceuticals Inc shares from India?

It is very easy to buy Cumberland Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cumberland Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Cumberland Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Cumberland Pharmaceuticals Inc stocks?

To start investing in Cumberland Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.